Published in J Neurol Neurosurg Psychiatry on June 11, 2010
Rehabilitation interventions in multiple sclerosis: an overview. J Neurol (2012) 1.04
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females. J Res Med Sci (2012) 0.77
Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis. Neurol Res Int (2011) 0.76
Do Physical Therapy Interventions Affect Urinary Incontinence and Quality of Life in People with Multiple Sclerosis?: An Evidence-Based Review. Int J MS Care (2015) 0.75
The effectiveness of bladder rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.75
[Multiple sclerosis : rehabilitation and long-term course]. Ophthalmologe (2014) 0.75
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology (2011) 2.39
Vocational rehabilitation. BMJ (2001) 2.33
Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology (2011) 2.04
De novo generation of neuronal cells from the adult mouse brain. Proc Natl Acad Sci U S A (1992) 1.97
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler (2006) 1.95
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun (2008) 1.90
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology (2012) 1.39
SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens (2007) 1.38
Sequential passage of influenza virus in embryonated eggs or tissue culture: emergence of mutants. Virology (1980) 1.38
Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res (2000) 1.35
Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci U S A (1996) 1.31
Induction of postnatal schwann cell death by the low-affinity neurotrophin receptor in vitro and after axotomy. J Neurosci (2000) 1.15
Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.14
How reliably do rheumatologists measure shoulder movement? Ann Rheum Dis (2002) 1.11
LIF receptor signaling modulates neural stem cell renewal. Mol Cell Neurosci (2004) 1.04
Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity. Qual Life Res (2006) 1.03
Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 1.02
Hospital doctors' attitudes towards older people. Intern Med J (2011) 1.01
Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J Biol Chem (2000) 0.96
Nerve growth factor signaling through p75 induces apoptosis in Schwann cells via a Bcl-2-independent pathway. J Neurosci (1999) 0.95
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Health Technol Assess (2008) 0.94
Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.94
The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear Res (1999) 0.94
Vitamin D deficiency in general medical inpatients in summer and winter. Intern Med J (2007) 0.93
The painful swollen calf. A comparative evaluation of four investigative techniques. Med J Aust (1986) 0.92
Regulation of neural stem cell differentiation in the forebrain. Immunol Cell Biol (1998) 0.92
Leukaemia inhibitory factor or related factors promote the differentiation of neuronal and astrocytic precursors within the developing murine spinal cord. Eur J Neurosci (1996) 0.92
Increased proliferation of precursor cells in the adult rat brain after targeted lesioning. Brain Res (1996) 0.91
Delirium in elderly general medical inpatients: a prospective study. Intern Med J (2007) 0.91
Validation of linear cerebral atrophy markers in multiple sclerosis. J Clin Neurosci (2008) 0.91
Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun (2007) 0.91
Illness perception and health-related quality of life in multiple sclerosis. Acta Neurol Scand (2007) 0.90
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. Ann Oncol (2006) 0.89
Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem (1999) 0.88
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. Neurology (2009) 0.88
Leukemia inhibitory factor promotes the neuronal development of spinal cord precursors from the neural tube. J Neurosci Res (1992) 0.87
A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci (1999) 0.87
Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure. Intern Med J (2010) 0.86
SOCS3 negatively regulates LIF signaling in neural precursor cells. Mol Cell Neurosci (2006) 0.86
Factors regulating the differentiation of neural precursors in the forebrain. Ciba Found Symp (1995) 0.86
Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome. J Neurol (2010) 0.85
A psychometric comparison of the positive and negative affect schedule across age and sex. Psychol Rep (2001) 0.84
HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens (2009) 0.83
Assessing individual clinical performance: a primer for physicians. Intern Med J (2011) 0.83
Analysis of small latent transforming growth factor-beta complex formation and dissociation by surface plasmon resonance. Absence of direct interaction with thrombospondins. J Biol Chem (1997) 0.83
Detection and incidence of neutralizing antibodies to interferon-alpha-n1. J Interferon Res (1989) 0.82
Cytogenetics of iris melanomas: disparity with other uveal tract melanomas. Cancer Genet Cytogenet (1998) 0.82
Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor. J Neurosci Res (2000) 0.82
Intelligence testing: bryter still and bryter? Nature (1987) 0.82
Synergy between TGF-beta 3 and NT-3 to promote the survival of spiral ganglia neurones in vitro. Neurosci Lett (1998) 0.81
Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels. Mol Psychiatry (2012) 0.81
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler (2010) 0.81
Development of the Assistance to Participate Scale (APS) for children's play and leisure activities. Child Care Health Dev (2009) 0.81
Negotiating hope with chronic obstructive pulmonary disease patients: a qualitative study of patients and healthcare professionals. Intern Med J (2012) 0.80
LIF potentiates the NT-3-mediated survival of spiral ganglia neurones in vitro. Neuroreport (1997) 0.80
Lineage specification of neuronal precursors in the mouse spinal cord. Proc Natl Acad Sci U S A (1995) 0.80
Fine tuning of adrenocortical functions by locally produced growth factors. J Endocrinol (1998) 0.80
Primary angiitis of the central nervous system: experience of a Victorian tertiary-referral hospital. Intern Med J (2013) 0.80
Outcomes of isolated tibial shaft fractures treated at level 1 trauma centres. Injury (2007) 0.79
Oral fluorescein angiography with the scanning laser ophthalmoscope in diabetic retinopathy: a case controlled comparison with intravenous fluorescein angiography. Eye (Lond) (2005) 0.79
Palliative care for patients with chronic obstructive pulmonary disease: exploring the landscape. Intern Med J (2012) 0.79
The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling. Prog Brain Res (2004) 0.79
Measurement of intracellular cytokines in MS patients treated with beta-interferon and association of a beta-interferon induced exacerbation with increased expression of gamma-interferon by monocytes. J Clin Neurosci (2001) 0.79
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis. J Clin Neurosci (2012) 0.79
Occupational exposure and risk of central nervous system demyelination. Am J Epidemiol (2013) 0.79
Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. Acta Haematol (2006) 0.78
Cryptococcal sacroiliitis. Ann Rheum Dis (1985) 0.78
Validity of the indicator 'death in low-mortality diagnosis-related groups' for measuring patient safety and healthcare quality in hospitals. Intern Med J (2010) 0.78
Variations in structures, processes and outcomes of community mental health teams for older people: a systematic review of the literature. Aging Ment Health (2012) 0.78
Diabetes risk reduction behaviours of rural postpartum women with a recent history of gestational diabetes. Rural Remote Health (2010) 0.77
Protracted form of encephalitis with good outcome. Med J Aust (1993) 0.77
Development of the Child's Challenging Behaviour Scale (CCBS) for mothers of school-aged children with disabilities. Child Care Health Dev (2009) 0.76
Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses. J Clin Neurosci (2006) 0.76
Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially. Clin Exp Immunol (2013) 0.76
A multipurpose muscle ergometer. J Biomech (1987) 0.75
Growth factors: potential therapeutic applications in neurology. J Neurol Neurosurg Psychiatry (1994) 0.75
Neurotrophin receptor expression and responsiveness by postnatal cerebral oligodendroglia. Neuroreport (2001) 0.75
Optimizing care for acute medical patients: the Australasian Medical Assessment Unit Survey. Intern Med J (2011) 0.75
The Assistance to Participate Scale to measure play and leisure support for children with developmental disability: update following Rasch analysis. Child Care Health Dev (2013) 0.75
Overview of shorthand medical glossary (OMG) study. Intern Med J (2015) 0.75
Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Qual Life Res (2014) 0.75
Regulation of the early development of the nervous system by growth factors. Pharmacol Ther (1994) 0.75
Geographical variation in incidence of knee arthroscopy for patients with osteoarthritis: a population-based analysis of Victorian hospital separations data. Intern Med J (2014) 0.75
An eye on the progress of joint consultation. Health Soc Serv J (1979) 0.75
Regulation of neural precursor differentiation in the embryonic and adult forebrain. Clin Exp Pharmacol Physiol (1995) 0.75
Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy. J Clin Neurosci (2004) 0.75
One-dimensional collective excitations in Ag atomic wires grown on Si(557). J Phys Condens Matter (2012) 0.75
Neural transplantation for Parkinson's disease: a critical appraisal. Aust N Z J Med (1991) 0.75
Management must take an active role. Health Soc Serv J (1979) 0.75
Multidisciplinary care for Guillain-Barré syndrome. Eur J Phys Rehabil Med (2011) 0.75
Update on the Child's Challenging Behaviour Scale following evaluation using Rasch analysis. Child Care Health Dev (2013) 0.75
The current state of multiple sclerosis genetic research. Ann Acad Med Singapore (2000) 0.75
[Not Available]. Helv Chir Acta (1956) 0.75
Do recombinant receptor assays provide affinity and potency estimates? Ann N Y Acad Sci (1997) 0.75
A look at the central issues surrounding joint consultation. Health Soc Serv J (1979) 0.75
Joint consultation as a form of joint regulation: a review. Health Serv Manpow Rev (1979) 0.75
[Interactions between steroidogenic cells and capillary endothelial cells in the adrenal gland]. Pathol Biol (Paris) (1999) 0.75